CIK 0001729427
- Non-accelerated filer
- Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 822318545
- Phone
- +1 800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock | +4,881 | 4,881 | ||
| 2024-04-08 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock | +40,000 | 201.57 | ||
| 2024-04-08 | Downs Christopher Chief Financial Officer | Grant or award · Restricted Stock Units | +40,000 | 241.57 | ||
| 2024-02-01 | Downs Christopher Chief Financial Officer | Purchase | +66,666 | $0.30 | $20K | 103,438 |
| 2024-02-01 | Downs Christopher Chief Financial Officer | Grant or award · Series A Warrant to purchase common stock | +66,666 | 94,906 | ||
| 2024-02-01 | Downs Christopher Chief Financial Officer | Grant or award · Series B Warrant to purchase common stock | +66,666 | 161,572 | ||
| 2023-08-22 | Downs Christopher Chief Financial Officer | Purchase | +27,000 | $1.27 | $34K | 36,772 |
| 2023-04-28 | Downs Christopher Chief Financial Officer | Exercise or conversion | +521 | 9,772 | ||
| 2023-04-28 | Downs Christopher Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −521 | 28,248 | ||
| 2023-04-17 | Downs Christopher Chief Financial Officer | Purchase | +3,100 | $3.20 | $10K | 9,251 |
| 2023-03-29 | Downs Christopher Chief Financial Officer | Grant or award · Restricted Stock Units | +6,067 | 28,768 | ||
| 2022-04-28 | Downs Christopher Chief Financial Officer | Grant or award · Restricted Stock Units | +250,000 | 681,000 | ||
| 2022-03-11 | Downs Christopher Chief Financial Officer | Grant or award | +33,000 | $0.31 | $10K | 184,500 |
| 2021-12-06 | Downs Christopher Chief Financial Officer | Purchase | +5,000 | $0.94 | $5K | 151,500 |
| 2021-11-19 | Downs Christopher Chief Financial Officer | Purchase | +4,500 | $1.15 | $5K | 146,500 |
| 2021-02-05 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock (right to buy) | +131,000 | 431,000 | ||
| 2020-08-24 | Downs Christopher Chief Financial Officer | Purchase | +142,000 | $2.04 | $290K | 142,000 |
| 2019-11-13 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock (right to buy) | +300,000 | 300,000 |
Page 1 of 1 · 18 trades